We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery

By HospiMedica International staff writers
Posted on 14 May 2025

Laparoscopic surgery for early gastric cancer has become increasingly popular worldwide due to its significant short-term benefits and comparable oncological outcomes to traditional open surgery. More...

However, accurately locating early-stage gastric cancer during laparoscopic procedures remains a challenge. This is because these tumors are confined to the mucous and submucosal layers, making them undetectable through standard examination of the serosa layer during the intraperitoneal view. To address this challenge, various methods such as preoperative dye injection and magnetic clip detection systems have been introduced to assist in locating tumors during surgery. Despite their usefulness, these existing techniques are often complex and lack both intuitiveness and durability. Now, a new study suggests the use of fluorescent soft robots to accurately identify tumors within the stomach, offering a potentially more effective and efficient solution in a clinically accessible manner.

The innovative approach, developed by researchers at Zhejiang University (Hangzhou, China), involves placing a metal clip at the tumor site and administering several soft robots labeled with Cy5, a widely used far-red fluorescent dye that is known for its bright signal and suitability for various applications in biological research. These robots are designed to autonomously gather around the metal clip. To assess the efficacy of this method, the research team performed animal studies, implanting clips in the stomachs of rats and administering capsules containing the soft robots. Using fluorescence detection, the location of the clips within the stomach was successfully identified. The findings from the study indicate that these soft robots may serve as a promising alternative for accurately marking gastric lesions during laparoscopic surgery, offering advantages in persistence and intuitiveness compared to other marking methods.

The fluorescent magnetic micro-robot presents several benefits for locating gastric lesions using approved metal clips. The robots are easy to produce, thanks to a straightforward fabrication process. They demonstrate excellent mobility, enabling them to navigate within the stomach and reach specific target locations. Additionally, they strongly adhere to the metal clips, ensuring precise marking of the lesions. One key advantage of the soft robots is their ability to function effectively in the acidic environment of the stomach. This property ensures that they maintain their functionality and fluorescence even when exposed to gastric acid. Furthermore, the robots can emit fluorescence for over eight hours, which aligns with the requirements of preoperative fasting, ensuring that the fluorescence remains visible and useful throughout the preoperative period. These combined advantages position the fluorescent magnetic micro-robot as a promising method for the real-time localization of gastric lesions during surgery.

“By leveraging their simple fabrication process, excellent mobility, strong adhesion, and ability to operate in an acidic environment while maintaining long-lasting fluorescence, these soft robots offer a potential solution for efficient and accurate localization of gastric lesions in clinical practice,” said Lifeng He, a researcher at Zhejiang University and author of the paper published in the journal Cyborg and Bionic Systems.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Diagnostic Ultrasound System
DC-80A
New
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.